Abstract
Melinacidin, a new antibacterial agent, blocked the synthesis of nicotinic acid and its amide in Bacillus subtilis cells. The inhibitory activity of the agent was reversed by nicotinic acid, its amide, or nicotinamide adenine dinucleotides, but not by l-kynurenine, l-3-hydroxykynurenine, l-hydroxyanthranilic acid, or quinolinic acid. These properties indicated that the antibiotic interferes with the conversion of quinolinic acid to nicotinate ribonucleotide by the enzyme quinolinate phosphoribosyl-transferase. However, the activity of a purified preparation of this enzyme derived from a Pseudomonas strain was not impaired by the antibiotic. This suggested that, in B. subtilis, melinacidin interferes with a reaction which occurs before the formation of quinolinic acid in the biosynthetic pathway leading to nicotinic acid. Failure of quinolinic acid to reverse melinacidin inhibition in B. subtilis cultures might be due to insufficient penetration of the cell membranes by quinolinate.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ohtsu E., Ichiyama A., Nishizuka Y., Hayaishi O. Pathways of nicotinamide adenine dinucleotide biosynthesis in nicotinic acid or nicotinamide requiring microorganisms. Biochem Biophys Res Commun. 1967 Dec 15;29(5):635–641. doi: 10.1016/0006-291x(67)90263-x. [DOI] [PubMed] [Google Scholar]
- Reusser F. Mode of action of antibiotic U-20,661. J Bacteriol. 1967 Jan;93(1):65–70. doi: 10.1128/jb.93.1.65-70.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]